Approaches to treatment of type 2 diabetes

被引：13
作者：
Bloomgarden, Zachary T. [1 ]
机构：
[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY USA
来源：
DIABETES CARE | 2008年 / 31卷 / 08期
关键词：
D O I：
10.2337/dc08-zb08
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1697 / 1703
页数：7
相关论文
共 50 条
  • [41] Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients
    Rosenstock, J
    Sugimoto, D
    Strange, P
    Stewart, JA
    Soltes-Rak, E
    Dailey, G
    [J]. DIABETES CARE, 2006, 29 (03) : 554 - 559
  • [42] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
    Rosenstock, Julio
    Brazg, Ronald
    Andryuk, Paula J.
    Lu, Kaifeng
    Stein, Peter
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (10) : 1556 - 1568
  • [43] Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus
    Sidhu, JS
    Kaposzta, Z
    Markus, HS
    Kaski, JC
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 930 - 934
  • [44] Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM - Results of two multicenter, randomized, placebo-controlled clinical trials
    Simonson, DC
    Kourides, IA
    Feinglos, M
    Shamoon, H
    Fischette, CT
    Aronoff, S
    Blonde, L
    Cefalu, W
    Clement, S
    Greenberg, C
    Levin, S
    Lucas, CP
    Macy, C
    Manning, J
    Marbury, TC
    McAdams, MJ
    Mezitis, NHE
    Miller, S
    Owens, D
    Sandler, J
    Schwartz, SL
    Shamoon, H
    Sosenko, J
    [J]. DIABETES CARE, 1997, 20 (04) : 597 - 606
  • [45] Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    Stratton, IM
    Adler, AI
    Neil, HAW
    Matthews, DR
    Manley, SE
    Cull, CA
    Hadden, D
    Turner, RC
    Holman, RR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258): : 405 - 412
  • [46] Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3
    Tuomi, T
    Sarelin, L
    Honkanen, EH
    Groop, LC
    Isomaa, B
    [J]. DIABETES CARE, 2006, 29 (02) : 189 - 194
  • [47] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    Turner, RC
    Holman, RR
    Stratton, IM
    Cull, CA
    Matthews, DR
    Manley, SE
    Frighi, V
    Wright, D
    Neil, A
    Kohner, E
    McElroy, H
    Fox, C
    Hadden, D
    [J]. LANCET, 1998, 352 (9131) : 854 - 865
  • [48] Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
    Turner, RC
    Cull, CA
    Frighi, V
    Holman, RR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (21): : 2005 - 2012
  • [49] Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes
    Xiang, AH
    Peters, RK
    Kjos, SL
    Marroquin, A
    Goico, J
    Ochoa, C
    Kawakubo, M
    Buchanan, TA
    [J]. DIABETES, 2006, 55 (02) : 517 - 522
  • [50] Drug therapy: Thiazolidinediones
    Yki-Jarvinen, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) : 1106 - 1118
12345